Hong Kong study shows small increased risk after Sinovac Biotech vaccine, but no significantly increased risk after BNT162b2 vaccine
Neurologic Symptoms Persistent for Many COVID-19 ‘Long-Haulers’
Main neurologic manifestations included brain fog for 81 percent and headache for 68 percent; 85 percent experience fatigue
AAO-HNS Issues Guidance for Bell’s Palsy Treatment During COVID-19
Corticosteroid therapy and/or antiherpes viral therapy recommended for patients developing Bell’s palsy after vaccination
Symptoms Persist in Many Discharged COVID-19 Patients
Most common symptoms at six months were fatigue or muscle weakness, sleep difficulties, anxiety or depression